1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia

Technology appraisal guidance [TA29] Published date: 26 September 2001

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...

Information for the public


  • Guidance on the use of fludarabine as second line therapy for B-cell chronic lymphocytic leukaemia 17 October 2002   PDF 38.15 KB